Search Results

Results 1 - 10 of 255 for stem cells. (4.88 seconds)
  • Studying neurodevelopmental disorders

    Stanford Medicine research on Timothy syndrome — which predisposes newborns to autism and epilepsy — may extend well beyond the rare genetic disorder to schizophrenia and other conditions.

  • Chuck Chan dies at 48

    The Stanford Medicine researcher was known for his groundbreaking work and his generous spirit as a mentor and colleague.

  • One treatment improves vaccine response

    Those with aging immune systems struggle to fight off novel viruses and respond weakly to vaccination. Stanford Medicine researchers were able to revitalize the immune system in mice.

  • Tachycardia unraveled

    Researchers engineered stem cell-derived heart tissues to study how tachycardia affects the heart and to uncover the inner workings of our body’s engine.

  • Cancer neuroscience discoveries give hope

    To drive their growth, many tumors hijack nervous system signals, including those needed for brain plasticity. Stanford Medicine discoveries are opening a promising new branch of oncology research.

  • Drug boosts nerve growth, muscle strength

    A drug that boosts strength in injured or aging mice restores connections between nerves and muscle and suggests ways to combat weakness in humans due to aging, injury or disease.

  • PhD lab coat ceremony

    Students in doctoral programs, from epidemiology to biomedical physics, don their lab coats and pledge their commitment to scientific ethics.

  • Jumble of autism genes categorized

    Combining two cutting-edge technologies, researchers revealed the impact of a multitude of genes that are associated with neurodevelopmental disorders, including autism, but whose effects on human brain development were previously unknown.

  • Stem cell therapy with Alzheimer’s

    In a Stanford Medicine study, scientists transplanted stem cells into mice and found reduction of brain abnormalities typical of Alzheimer’s disease.

  • Depression after stroke

    Scientists discover a biomarker in stroke survivors, suggesting that chemical changes after stroke can lead to depression. The findings may pave the way toward treatment.